MONTANOVA CAPITAL, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001569064
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 96 positions · Total reported value $2.93B · Top-10 concentration 43.9% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 47.3% · 21 new · 17 cut · 14 exited
Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking
In its Q4 2024 13F filing, MONTANOVA CAPITAL, LLC disclosed 96 equity positions with a combined reported value of $2.93B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were BHVN ($209.92M), SPY ($205.13M), ARQT ($158.79M). By sector, the heaviest allocations are Health Care 45.0%, Technology 13.4%. Versus the prior quarter, allocation shifted toward Health Care (+3.3pp), Industrials (+1.7pp) and away from Technology (-2.3pp), Communication Services (-2.7pp).
Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 69% of names.
The largest new positions opened in Q4 2024 were LEGN ($113.77M), IMTX ($36.01M), RCKT ($32.27M).
Of the 14 positions fully exited versus the prior quarter, the largest were AAPL ($78.32M), ACLX ($57.62M), RPRX ($52.80M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
Fully Exited (vs previous quarter)
- AAPL APPLE INC · prev qtr: $78.32M
- ACLX ARCELLX INC · prev qtr: $57.62M
- RPRX ROYALTY PHARMA PLC · prev qtr: $52.80M
- T AT&T INC · prev qtr: $50.28M
- KDP KEURIG DR PEPPER INC · prev qtr: $26.35M
- LVS LAS VEGAS SANDS CORP · prev qtr: $24.37M
- INTC INTEL CORP · prev qtr: $23.46M
- PINS PINTEREST INC · prev qtr: $19.94M
Insider Transactions (Form 4)
Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-20 | Opt exercise | Veradermics, Inc | 151,000 | — | SEC filing |
| 2026-08-20 | Opt exercise | Veradermics, Inc | 149,000 | — | SEC filing |
| 2026-08-19 | Sell | Veradermics, Inc | 59,399 | $107.25 | SEC filing |
| 2026-08-19 | Sell | Veradermics, Inc | 690,601 | $107.25 | SEC filing |
Fund Profile
Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-79962 (status: Approved), registered 2014-06-26
- Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
- Website: montanova.com
Portfolio Structure
- 96 positions · $5.47B reported value (Q2 2026)
- Top 10 holdings = 49.1% of reported value
- Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
- Average position size: $56.96M
Sector Tilt
- Health Care 50.9%
- Information Technology 14.5%
- Consumer Discretionary 8.3%
- (classified holdings cover 83% of value)
Quarterly Activity
- Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
- 32 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.62M | $209.92M | 7.15% | Add | |
| 2 |
|
350.00K | $205.13M | 6.99% | Reduce | |
| 3 |
|
11.40M | $158.79M | 5.41% | Add | |
| 4 |
|
1.44M | $120.19M | 4.10% | Hold | |
| 5 |
|
3.50M | $113.77M | 3.88% | New | |
| 6 |
|
8.96M | $113.16M | 3.86% | Add | |
| 7 |
|
1.61M | $111.26M | 3.79% | Reduce | |
| 8 |
|
170.34K | $99.73M | 3.40% | Add | |
| 9 |
|
10.20M | $79.79M | 2.72% | Add | |
| 10 |
|
351.28K | $77.07M | 2.63% | Hold | |
| 11 |
|
464.14K | $76.66M | 2.61% | Hold | |
| 12 |
|
1.14M | $70.84M | 2.41% | Add | |
| 13 |
|
345.91K | $68.31M | 2.33% | Reduce | |
| 14 |
|
163.63K | $66.08M | 2.25% | Reduce | |
| 15 |
|
2.25M | $59.83M | 2.04% | Add | |
| 16 |
|
6.78M | $50.53M | 1.72% | Add | |
| 17 |
|
118.40K | $49.90M | 1.70% | Add | |
| 18 |
|
1.15M | $48.44M | 1.65% | Hold | |
| 19 |
|
514.92K | $46.99M | 1.60% | Reduce | |
| 20 |
|
251.64K | $44.87M | 1.53% | Add | |
| 21 |
|
5.08M | $44.22M | 1.51% | Reduce | |
| 22 |
|
245.53K | $42.62M | 1.45% | Add | |
| 23 |
|
74.20K | $42.49M | 1.45% | Reduce | |
| 24 |
|
4.91M | $41.61M | 1.42% | Add | |
| 25 |
|
337.42K | $40.76M | 1.39% | Reduce | |
| 26 |
|
436.39K | $40.38M | 1.38% | Reduce | |
| 27 |
|
75.20K | $38.04M | 1.30% | Reduce | |
| 28 |
|
226.32K | $37.71M | 1.28% | Reduce | |
| 29 |
|
5.07M | $36.01M | 1.23% | New | |
| 30 |
|
397.68K | $35.52M | 1.21% | Add | |
| 31 |
|
200.66K | $33.47M | 1.14% | Hold | |
| 32 |
|
2.57M | $32.27M | 1.10% | New | |
| 33 |
|
12.32M | $30.91M | 1.05% | Reduce | |
| 34 |
|
103.64K | $30.04M | 1.02% | Hold | |
| 35 |
|
738.41K | $29.53M | 1.01% | Reduce | |
| 36 |
|
980.00K | $29.50M | 1.00% | New | |
| 37 |
|
155.20K | $27.47M | 0.94% | New | |
| 38 |
|
772.41K | $25.81M | 0.88% | New | |
| 39 |
|
793.19K | $25.31M | 0.86% | New | |
| 40 |
|
176.45K | $25.21M | 0.86% | New | |
| 41 |
|
1.72M | $25.20M | 0.86% | Hold | |
| 42 |
|
180.76K | $24.27M | 0.83% | New | |
| 43 |
|
12.34M | $20.86M | 0.71% | Hold | |
| 44 |
|
3.69M | $20.53M | 0.70% | Hold | |
| 45 |
|
139.99K | $20.24M | 0.69% | Add | |
| 46 |
|
200.65K | $19.48M | 0.66% | New | |
| 47 |
|
115.44K | $17.65M | 0.60% | Add | |
| 48 |
|
38.34K | $16.09M | 0.55% | New | |
| 49 |
|
3.34M | $15.69M | 0.54% | Add | |
| 50 |
|
5.73M | $14.16M | 0.48% | Hold | |
FAQ
What did MONTANOVA CAPITAL, LLC buy in 2024-Q4?
In its 2024-Q4 13F filing, MONTANOVA CAPITAL, LLC reported 96 equity positions worth $2.93B in aggregate; its largest disclosed positions were BHVN ($209.92M), SPY ($205.13M), ARQT ($158.79M).
How large is MONTANOVA CAPITAL, LLC's portfolio?
MONTANOVA CAPITAL, LLC reported $2.93B of long equity holdings across 96 positions as of 2024-Q4. Top-10 holdings account for 43.9% of reported value.
What is MONTANOVA CAPITAL, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.